Urgency Urinary Incontinence
14
0
5
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 14 trials
100.0%
+13.4% vs benchmark
29%
4 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 7 completed trials
Clinical Trials (14)
Long-Term Effectiveness and Safety of Sacral Neuromodulation With InterStim for Lower Urinary Tract Dysfunction
Reduction in Number of Botox Injections for Urgency Urinary Incontinence
Magnetic Stimulation as a Treatment for Female Urinary Incontinence
Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women
Bladder Training With or Without Biofeedback-Assisted Pelvic Floor Muscle Training for Women With Wet Overactive Bladder
Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence
Investigation of Brain Mechanisms Involved in the Urinary Continence Mechanism Associated With Aging
Investigation of Brain Mechanisms Involved in Urgency Urinary Incontinence
Reduced-dose Botox for Urgency Incontinence Among Elder Females
Behavioral Interventions Versus Pelvic Floor Muscle Therapy as Adjuncts to Anticholinergic Pharmacotherapy for Urgency Urinary Incontinence: A Non-Inferiority Trial
Repetitive Transcranial Magnetic Stimulation (rTMS) on Neurogenic Overactive Bladder in Stroke
Sacral Neuromodulation and the Microbiome
eCoin Tibial Nerve Stimulation for OAB
A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence